x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychedelics Today

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.

science life sciences

All Episodes

01:03:34

PT575 – The Mystical Roots of Psychedelics: Exploring...

Psychedelics Today ·

2024/12/20

In this episode, Joe interviews Shauheen Etminan, Ph.D.: co-founder of VCENNA, a drug discovery and development company, and Magi Ancestral Supplements, which sells nootropics inspired by ancient Eastern traditions. He discusses his journey into the world of plant extraction, how he first discovered compounds like Haoma and Harmaline, and why he decided to bring Iranian tradition to the psychedelic renaissance. He explores the similarities between psychedelics and experiences found in mystical

en

01:24:55

PT574 – Transpersonal Connections, The Body's Memory,...

Psychedelics Today ·

2024/12/17

In this episode, Joe interviews Paul Grof: research psychiatrist, clinician, author, brother of Stanislav, professor of psychiatry at the University of Toronto, and director of the Ottawa Mood Disorders Center. He talks about his extensive career in psychiatry, and how trying to understand the cause of mood disorders led him to focusing on the very nature of consciousness. He believes that consciousness is a collaborative creation between the brain, body, and external fields, and that the key to

en

01:09:20

PT573 – The War on Drugs: The DEA’s Attempt to...

Psychedelics Today ·

2024/12/13

In this episode, Joe interviews Kat Murti: executive director of Students for Sensible Drug Policy (SSDP), the largest nationwide network of students fighting to replace the War on Drugs with policies rooted in evidence, compassion, and human rights. She talks about how she became interested in drug policy, which not surprisingly aligns with the many problems of The War on Drugs: how it’s a war on people, personal liberty, and our communities; how laws are not effective in enforcing morality; and

en

01:17:55

PT572 – The Potential of Buprenorphine, the Risks of...

Psychedelics Today ·

2024/12/10

In this episode, Joe interviews Howard Kornfeld, MD: renowned pain medicine expert, addiction specialist, early pioneer in psychedelic medicine, and currently the director of recovery medicine at Recovery Without Walls. As a leader in the utilization of buprenorphine, he talks about how it came about as a treatment for addiction and chronic pain, its similarities to MDMA, and how its fast-tracked FDA approval could give us clues on how to get MDMA approved. He also dives into the history of

en

01:08:31

PT571 – Regulation, Decriminalization, and Religious...

Psychedelics Today ·

2024/12/06

In this episode, Joe interviews Veronica Lightning Horse Perez: therapist, speaker, author, activist, and co-chief proponent for the Natural Medicine Health Act of 2022 (Prop 122); and Sean McAllister: attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines, and one of the drafters of Prop 122. This episode was recorded live at the Plant Medicine Cafe in Denver, CO – which served as an unofficial Prop 122 headquarters – and cohosted by

en

46:00

PT570 – How Family Healing Shapes Veteran Recovery,...

Psychedelics Today ·

2024/12/03

In this episode, Joe interviews two members of the Heroic Hearts Project: Founder and President, Jesse Gould; and Director of Development and Head of Family Relations, Allison Wilson. Gould gives a background of Heroic Hearts Project and discusses their current projects and future goals, and Wilson talks about her nonprofit, The Hope Project, and its recent merger with HHP to bring more of a focus to the other side of veteran healing: the families of veterans. While Heroic Hearts and other

en

01:30:04

PT569 – Is Cannabis a Psychedelic? Exploring the...

Psychedelics Today ·

2024/11/29

In this episode, Victoria interviews Max Montrose: Founder of the Trichome Institute, a company offering online courses and certifications on cannabis. Montrose explores the scientific and sensory aspects of cannabis, diving into the role of the aromatic compound, indole, and how the fresher and more aromatic (usually pungent) the flower is, the higher chance for having a more psychedelic experience. He dives into ways to maximize the psychedelic nature of cannabis, largely through “interprening,”

en

01:09:41

PT568 – The 3-Axis Framework: A New Model for...

Psychedelics Today ·

2024/11/26

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces his 3-axis framework for psychedelic integration, which looks at the personal, the transpersonal, and, with time, seeing how the lessons learned from non-ordinary experiences and personal work are expressing to the world: How can we use what we've learned to show up better? How can we use our gifts to be

en

01:13:34

PT567 – Sex and Psychedelics: Healing Through Altered...

Psychedelics Today ·

2024/11/22

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her personal journey with psychedelics and how they unlocked deep trauma, allowing her to develop a level of comfort with intimacy, love, and her sexuality. She talks about the parallels between psychedelic journeys and sexual experiences, and how both can be gateways to unexplored parts of ourselves, as

en

01:33:45

PT566 – Standards, Ethics, and Integration:...

Psychedelics Today ·

2024/11/19

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standards – especially for at-home ketamine – before the government imposes its own standards on us. Citing the Matthew Perry case and other bad behavior from

en

01:08:59

PT565 – From Individualism to Connection: How...

Psychedelics Today ·

2024/11/15

In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketamine-assisted therapy and psychedelic integration. He talks about what he feels is one of the largest factors in our mental health crisis: the individualistic and neoliberal lens Western culture has placed on mental health and how it neglects the massive systemic and relational factors that are affecting

en

01:08:38

PT564 – How Safe is Ibogaine Therapy? The Delicate...

Psychedelics Today ·

2024/11/11

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for treatment. So he worked to create what was needed: a combination of a hospital, mental health treatment facility, retreat center, and resort, with the proper infrastructure in place, employees with ICU experience,

en

01:29:52

PT563 – Why Psychedelic Research is Booming: Current...

Psychedelics Today ·

2024/11/08

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, trials, companies, and over 2000 categorized research articles. When Wolswijk began Blossom, he was barely able to fill a weekly newsletter, and now he’s adding a new study nearly every day, perfectly illustrating the exponential growth in psychedelic research. He talks about why so much research is

en

45:51

PT562 – Ketamine-Assisted Therapy at Work? The Future...

Psychedelics Today ·

2024/11/05

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees. She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an

en

55:18

PT561 – Psychedelics Lately – Massachusetts' Question...

Psychedelics Today ·

2024/11/01

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they’ll meet each month to talk about the most interesting stories in psychedelics. The main story this month is the fate of Massachusetts’ Question 4: Regulated Access to Psychedelic Substances Initiative (The Natural Psychedelic Substances Act). They discuss what they like about the bill, its opposition, and its support, including

en

01:01:40

PT560 – Philosophy and Psychedelics: Can Metaphysics...

Psychedelics Today ·

2024/10/29

In this episode, Joe interviews Dr. Peter Sjöstedt-Hughes: philosopher, lecturer at the University of Exeter, co-director of the Breaking Convention conference, and author who most recently co-edited Philosophy and Psychedelics: Frameworks for Exceptional Experience. He discusses how the work of William James and an early psilocybin experience led him to an interest in philosophy and psychedelics, and he dives deep into several philosophical concepts: panpsychism, pantheism, ethical pluralism,

en

40:45

PT559 – The Penn Psychedelics Collaborative and the...

Psychedelics Today ·

2024/10/25

In this episode, Joe interviews 4 members of the Penn Psychedelics Collaborative: Co-Founder, Taylor Andrews Flatt, PMHNP; Associate Director, Victor Pablo Acero, Ph.D.; Professor in Fine Arts and Co-Director of the Weitzman School of Design, Jackie Tileston; and Executive Director and Director of the Penn Program for Mindfulness, Michael Baime, MD. Recorded earlier this month at the PhilaDelic conference – one of the primary initiatives of the PPC – they discuss their paths to psychedelics and why

en

01:13:56

PT558 – What You Need to Know About Massachusetts'...

Psychedelics Today ·

2024/10/22

In this episode, Joe interviews two people on the frontlines of the campaign for Massachusetts' Question 4: The Natural Psychedelic Substances Act: Graham Moore and Community Engagement Director, Jamie Morey. They discuss the specifics of the initiative, listed on the ballot as the “Limited Legalization and Regulation of Certain Natural Psychedelic Substances,” including the removal of criminal penalties for limited personal use, and the establishment of a regulatory agency that will provide

en

01:11:59

PT557 – Psychedelic Education Through a Healing...

Psychedelics Today ·

2024/10/18

In this episode, Joe interviews Diana Quinn, ND: naturopathic doctor, healing justice practitioner, and director of clinical education at the Naropa Center for Psychedelic Studies, where she directs their Psilocybin Facilitator Training certificate program. She discusses her path from anthropology to naturopathy, and eventually to psychedelics and activism, finding a framework for psychedelic education grounded in healing justice, which recognizes the impact of collective trauma on all of us, seeks

en

01:13:05

PT556 – The FDA, MDMA, and Public Perception: Was the...

Psychedelics Today ·

2024/10/15

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS’ public benefit subsidiary. Doblin tells his side of the story: that the FDA’s concerns with double blinding not working had been fully addressed ahead of time, that they had negotiated agreements that were no longer agreed to when new FDA employees came on board, that there was a lot of confusion from going

en

755 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter